Congratulations Dr. Candice Santoro on best poster at #ASBrS2025

Phenomenal summary of where we are at and the future of robotic mastectomy by Dr. Piltin #ASBrS2025

RT @ASBrS: Look at metrics to improve quality in the community. #asbrs2025

Fantastic summary of the quality improvement work done at Atrium Health by Dr. White. Knowing your data and educating providers can have a profound positive impact on care. #asbrs2025

Thank you @ASBrS for the opportunity to present our work on de novo metastatic breast cancer validating the prognostic model created by @JenniferPlichta. The calculator can be found here: #asbrs2025

I’m so proud to be a fellow at Mayo where our faculty are clearly interested in education and to have the opportunity to learn from great educators like @RoyPhit @MayoClinicSurg

In order to properly read a clinical trial today you have to read the publication, the other publication on QoL findings, the prior publication to find the methods, inclusion criteria, and patient characteristics, and then 7 supplements.

Some really great findings in the eposters including 0 nipple recurrences at 8 yrs median follow up in a large cohort of BRCA patients undergoing NSM and experiences with NET and axillary staging. Thanks to @OKantorMD for the impromptu session.

Fantastic synthesis of evidence on the use of genomic assays to guide treatment decisions in patients with HR+HER2- cN+ disease by @OKantorMD at #SSO2025

Interesting findings on fellow experience over time from Dr. Mrdutt on behalf of ASBrS and SSO.

I’m surprised by the finding that 22% of patients had a sentinel node with a 4-5% mastectomy rate in the population.

What I heard: 30% upgrade rate, about 10% recurrence, just over half of which are invasive. >=2mm margin width, negative margins, endocrine therapy associated with decreased local recurrence.

#SSO2025 is getting started with some great data on pleomorphic and florid LCIS

Excited to share some of our work on occult malignancy at the time of CPM and referral of rural breast cancer patients at @SocSurgOnc #SSO2025

Some posters I found aesthetically pleasing from #SABCS

Great debate on universal germline genetic testing at #SABCS24. Where do you stand?

INSEMA presentation: patients >50yo with T1 cN0 G1-2 ER+ HER2- breast cancer treated with BCS and RT can safely omit SLN surgery.#SABCS24 .

Fantastic posters this morning on axillary surgery after NACT and PROs after oncoplastic surgery!

Excited to present my cost effectiveness analysis of approaches to axillary management in the setting of CPM at #SABCS today

Dr. Wong’s breakdown of when to dissect and when to radiate and summary of the available evidence was 🔥🔥🔥@SABCSSanAntonio #sabcs